All In MedTech

FDA Clearance Tracker · P980048-S002

BAK/CERVICAL (BAK/C) (R) INTERBODY FUSION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 19, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 19, 2002

Approved

Time to decision

362 days

Received Jun 22, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P980048-S002
Device name
BAK/CERVICAL (BAK/C) (R) INTERBODY FUSION SYSTEM
Applicant location
Minneapolis, MN
Received
Jun 22, 2001
Decided
Jun 19, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol
Original approval
P980048

Device type

Device class
Class II
Regulation
21 CFR 888.3080

Every decision under product code MAX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE POST-APPROVAL STUDY PROTOCOL FOR THE BAC/C DEVICE. THE POST-APPROVAL STUDY HAS BEEN SUBMITTED TO COMPLY WITH THE CONDITIONS OF APPROVAL OUTLINED IN THE APRIL 20, 2001, APPROVAL ORDER FOR P980048.

Source documents

Other decisions for Sulzer Spine-Tech

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.